Real-World Evidence for Decisions in Diabetes

Novo Nordisk A/S (Novo Nordisk) – Bagsværd, Denmark

We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat. We employ more than 50,000 people in 80 offices around the world, and market our products in 170 countries.

Role within REDDIE

In REDDIE, Novo Nordisk contributes with expertise in clinical trials, drug development and regulatory processes, health economics, and analysis of real-world evidence data. Novo Nordisk will bring the industry perspective to this partnership and provide a link to the Hypo-RESOLVE consortium.

Main contacts

Photo of Matthias Müllenborn
Matthias Müllenborn

Senior Director, Public-Private Partnerships - Global Medical Affairs

Photo of Mari-Anne Gall
Mari-Anne Gall

Senior Medical Expert, Medical & Sciences - Clinical Drug Development